Ceredex Value Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.2M Buy
118,900
+4,150
+4% +$862K 0.8% 35
2026
Q1
$24.2M Buy
+114,750
New +$24.7M 0.76% 39

Other funds holding CAH

Ceredex Value Advisors's CAH Position: Q2 2026 in Review

Ceredex Value Advisors increased its Cardinal Health (CAH) stake by 3.6% in Q2 2026, buying an estimated $862K and bringing the position to 118,900 shares worth $28.2M. The position accounts for 0.8% of the portfolio, ranked #35.

Ceredex Value Advisors first reported a position in CAH in Q1 2026 and has held it in 2 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Ceredex Value Advisors held 118,900 shares of Cardinal Health worth $28.2M as of Q2 2026.
  • Ceredex Value Advisors bought 4,150 Cardinal Health shares in Q2 2026, an estimated $862K.
  • Cardinal Health made up 0.8% of Ceredex Value Advisors's portfolio in Q2 2026, its #35 holding.
  • Ceredex Value Advisors first reported a position in Cardinal Health in Q1 2026 and has held it in 2 quarters since.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Ceredex Value Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.